Sign In
NewsRadar


June 11 - 13, 2014
Hotel InterContinental Vienna
EVCA Symposium 2014
The EVCA Symposium is the event of the year for private equity’s stakeholders to look beyond day-to-day operations and exchange ideas that will shape the growth path of the industry. This is an unparalleled opportunity for private equity’s leaders to identify breakthrough strategies that will catapult the industry forward and solidify its position as a transforming economic force.



New Agenda Packed with Mission-Critical Content
The EVCA is dedicated to delivering the highest quality insight and analysis to propel the industry forward. As part of this commitment, this year’s Symposium will focus its content on bolstering the private equity industry’s position as a global influencer and change agent. Going beyond operational issues, this strategic program will hone in on the topics that will define the industry and impact economies for years to come:

Global Capital Markets: Mapping Out Certainty Amidst Change
Boosting Investor Appetite for Europe
Smart Cities, Smart Technology, Smart Society
Growth through Innovation & Entrepreneurship


More information about this event
Data


19,509
Tech investments
From our Online Data Service
12,553
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Mar 5€78.0MInternet commerce
Mar 4€1.5MBusiness applications
Feb 24€1.5MDigital signal processing
Feb 24€8.7MBiopharmaceuticals
Feb 24€0.4MImaging
Feb 24€0.8MInternet commerce
Feb 24N/AConsumer applications

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Mar 5
farfetch.com
farfetch announces a us$86 million series e round of investment led...

Mar 2
Iris Capital
adotmob raises € 1m from iris capital and kerala ventures

Mar 2
High-Tech Gründerfonds Management
htgf portfolio company outfittery raises $20 million led by new inv...

Mar 2
Themis Bioscience
themis bioscience’s chikungunya vaccine study results published in ...

Mar 2
Alizé Pharma
alizé pharma launches phase ii clinical trial of azp-531 in prader-...





About usContact usLegal Information
Copyright © 1999-2015
Emerging Technology Research Europe Inc. All rights reserved.